Brian Low Financial Group
ABBV icon

Brian Low Financial Group’s AbbVie ABBV Stock Holding History

Brian Low Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.39M Buy
9,147
+379
+4% +$97.2K 1.33% 19
2026
Q2 		$2.21M Buy
8,768
+1,118
+15% +$241K 1.29% 21
2026
Q1 		$1.66M Buy
7,650
+631
+9% +$140K 1.13% 24
2025
Q4 		$1.6M Buy
7,019
+552
+9% +$126K 1.14% 21
2025
Q3 		$1.5M Buy
6,467
+1,471
+29% +$300K 1.16% 17
2025
Q2 		$927K Buy
+4,996
New +$928K 0.87% 30

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Brian Low Financial Group's ABBV Position: Q3 2026 in Review

Brian Low Financial Group increased its AbbVie (ABBV) stake by 4.3% in Q3 2026, buying an estimated $97.2K and bringing the position to 9,147 shares worth $2.39M. The position accounts for 1.33% of the portfolio, ranked #19.

Brian Low Financial Group first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Brian Low Financial Group held 9,147 shares of AbbVie worth $2.39M as of Q3 2026.
  • Brian Low Financial Group bought 379 AbbVie shares in Q3 2026, an estimated $97.2K.
  • AbbVie made up 1.33% of Brian Low Financial Group's portfolio in Q3 2026, its #19 holding.
  • Brian Low Financial Group first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Brian Low Financial Group's 13F filing for Q3 2026, filed 28 Oct 2026.